Lallemand Health Solutions and Nimble Science to use SIMBA Capsule for pioneering gut research

20 Sep 2024 — Probiotics R&D company Lallemand Health Solutions will conduct a clinical trial to assess the efficacy of the Bacillus subtilis R0179 strain in alleviating symptoms of Small Intestinal Bacterial Overgrowth (SIBO) in collaboration with Nimble Science, a small intestine sampling technology expert, using its new SIMBA Capsule.